Distribution Agreement with CapitalBio
BioDot, the leading supplier of system tools for the research, development, and commercialization of diagnostic tests has finalized a distribution partnership with CapitalBio.
CapitalBio has a broad product offering and expertise in the biochip arena which will compliment BioDot's quantitative, non-contact dispensing. Under the terms of the agreement, CapitalBio can promote and sell BioDot products outside of the Shanghai province specific to government accounts such as the Center of Disease Control and the Inspection and Quarantine facilities. In addition, CapitalBio and BioDot have agreed to work together to position both companies products for complete range of biochip and molecular diagnostic applications. “The agreement is truly synergistic”, stated Guangwei Fan, Sales Manager at CapitalBio, “as we are now able to expand our applications focus into markets such as Lateral Flow, where BioDot is a leader”. Tom Tisone, President of BioDot commented that “with CapitalBio's extensive sales force, the agreement will give BioDot China support into regions where we don't have coverage.”
BioDot is the leading supplier of system tools for the research, development and commercialization of diagnostic tests. Our mission is to enable, inspire and educate scientists to commercialize their R&D ideas through to manufactured product. Using its core competencies in low volume non-contact dispensing, cutting/slitting, lamination, and strip assembly, BioDot has developed a range of equipment for the research and development, and manufacture of rapid tests.
CapitalBio Corporation is located in Beijing and is China’s leading developer and marketer of diagnostic biochips, microarray related instruments and services, and commercializes total health-care solutions including a broad range of innovative products for genomic, proteomic research, clinical applications and address wider human health needs.
The life science company, founded in 2000, currently has more than 500 employees and is closely linked to the National Engineering Research Centre for Beijing Biochip Technology. Visit www.capitalbio.com for more information.
Barbara McIntosh, VP Sales & Marketing